The event convenes leading policymakers and experts—including Global Fund Executive Director Peter Sands—along with those on the frontlines of the battle with the three deadly diseases, to reflect on the impact that the Global Fund has had, what is unique about its approach, and what now needs to be done to take the next steps to combat these killer diseases.
How can the resources of the private sector be more effectively leveraged to help battle three of the world’s most devastating communicable diseases? This was the topic on Monday when Patrik Silborn, the head of the Private Sector Engagement Department for the Global Fund to Fight AIDS, Tuberculosis and Malaria, joined in a roundtable discussion in Tokyo, where he presented …
The Japan Center for International Exchange (JCIE) and its Friends of the Global Fund, Japan (FGFJ) initiative, organized a series of events during the Fifth Tokyo International Conference on African Development (TICAD V).
At the G20 Business Summit held in Seoul this week, Takeda Pharmaceutical President and CEO Yasuchika Hasegawa and Anglo American Chief Executive Cynthia Carroll co-convened a working group meeting on access to healthcare.
On March 18, 2010, Takeda Pharmaceutical and the Global Fund announced an exciting new partnership in which Takeda will contribute JPY1 billion (approximately US$10 million) over ten years for the Global Fund’s programs.